BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GrantMe Tennessee//grantme.click//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mechanisms that Impact Cancer Risk with Use of Incretin Mimeti
 cs (R21 Clinical Trial Not Allowed)
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:9f763fd4-f336-436a-8c8b-25d8806aa218-close@grantme.click
DTSTAMP:20261006T225007Z
DTSTART;VALUE=DATE:20270107
DTEND;VALUE=DATE:20270108
SUMMARY:Deadline: Mechanisms that Impact Cancer Risk with Use of Incretin M
 imetics (R21 Clinical Trial Not Allowed)
URL:https://grantme.click/grants/9f763fd4-f336-436a-8c8b-25d8806aa218
DESCRIPTION:Confirm the deadline and time zone on the funder's official pag
 e.
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P30D
DESCRIPTION:30 days left: Deadline: Mechanisms that Impact Cancer Risk with
  Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
END:VALARM
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-P7D
DESCRIPTION:7 days left: Deadline: Mechanisms that Impact Cancer Risk with 
 Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
END:VALARM
END:VEVENT
END:VCALENDAR